SMALLMACHINES

SMALLMACHINES is a microfluidics-driven diagnostics company advancing the future of intelligent, accessible healthcare. We develop AI-powered diagnostic platforms that integrate lab-on-a-chip technology with real-time analysis, delivering lab-grade results directly at the point of care. Through innovations in microfluidics, biosensing, and AI, we are redefining Point-of-Care Testing (PoCT) to make high-performance diagnostics available in clinical settings and remote environments alike. Our core technologies include: DELISA: A digital immunoassay platform for ultra-sensitive detection of low-concentration and small-molecule biomarkers Cellop: A compact analyzer for automated cell counting, morphology, and viability testing WHOPE: A 5-part differential CBC analyzer using vision AI for real-time hematology and pathology analysis OEM/ODM Lab-on-a-Chip Solutions: End-to-end design and manufacturing services for diagnostic and biotech partners Headquartered in South Korea, SMALLMACHINES collaborates with global healthcare providers and research institutions to deliver the next generation of decentralized diagnostics.

• Employees 10
• Founded 2014